Financial statements Molecular Worldwide

Balance sheet of Molecular Worldwide

Company age:
Age:
23 y. 1 m. 25 d.
Share capital:
Share capital:
280 000 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of MOLECULAR WORLDWIDE

Year
2018
2019
2020
2021
2022
2023
Total assets 18 224 820,36 22 008 911,02 17 921 358,34 23 026 395,71 24 984 457,27 28 016 460,08
A. Fixed assets 1 128 599,03 1 101 122,61 1 167 679,60 1 591 811,10 1 384 007,67 1 111 514,48
B. Current assets 17 096 221,33 20 907 788,41 16 753 678,74 21 434 584,61 23 600 449,60 26 904 945,60
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 18 224 820,36 22 008 911,02 17 921 358,34 23 026 395,71 24 984 457,27 28 016 460,08
A. Equity 8 603 709,28 7 937 503,19 11 056 615,83 13 908 099,59 17 839 702,52 10 511 997,88
B. Liabilities and provisions for liabilities 9 621 111,08 14 071 407,83 6 864 742,51 9 118 296,12 7 144 754,75 17 504 462,20
I. Long-term liabilities 157 691,46 171 551,67 139 936,80 157 491,60 320 377,57 312 084,55
II. Short-term liabilities 6 714 570,37 12 315 901,46 3 482 553,69 4 311 817,73 4 264 289,70 14 711 516,56
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.